IE51514B1 - Pharmaceutical compositions containing dihydro-1h-pyrrolizine-3,5(2h,6h)-dione as the active compound and their use as cognition activators - Google Patents

Pharmaceutical compositions containing dihydro-1h-pyrrolizine-3,5(2h,6h)-dione as the active compound and their use as cognition activators

Info

Publication number
IE51514B1
IE51514B1 IE2133/81A IE213381A IE51514B1 IE 51514 B1 IE51514 B1 IE 51514B1 IE 2133/81 A IE2133/81 A IE 2133/81A IE 213381 A IE213381 A IE 213381A IE 51514 B1 IE51514 B1 IE 51514B1
Authority
IE
Ireland
Prior art keywords
dione
pyrrolizine
dihydro
grams
composition according
Prior art date
Application number
IE2133/81A
Other languages
English (en)
Other versions
IE812133L (en
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IE812133L publication Critical patent/IE812133L/xx
Publication of IE51514B1 publication Critical patent/IE51514B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IE2133/81A 1980-09-15 1981-09-14 Pharmaceutical compositions containing dihydro-1h-pyrrolizine-3,5(2h,6h)-dione as the active compound and their use as cognition activators IE51514B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18694580A 1980-09-15 1980-09-15
US06/290,114 US4372966A (en) 1980-09-15 1981-08-07 Use of dihydro-1H-pyrrolizine-3,5(2H,6H)-dione as a cognition activator

Publications (2)

Publication Number Publication Date
IE812133L IE812133L (en) 1982-03-15
IE51514B1 true IE51514B1 (en) 1987-01-07

Family

ID=26882585

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2133/81A IE51514B1 (en) 1980-09-15 1981-09-14 Pharmaceutical compositions containing dihydro-1h-pyrrolizine-3,5(2h,6h)-dione as the active compound and their use as cognition activators

Country Status (15)

Country Link
US (1) US4372966A (enExample)
EP (1) EP0048132B1 (enExample)
AU (1) AU545556B2 (enExample)
CA (1) CA1154679A (enExample)
DD (1) DD201797A5 (enExample)
DE (1) DE3165563D1 (enExample)
ES (1) ES8206526A1 (enExample)
FI (1) FI812853A7 (enExample)
GR (1) GR75026B (enExample)
HU (1) HU184883B (enExample)
IE (1) IE51514B1 (enExample)
IL (1) IL63663A (enExample)
NO (1) NO813122L (enExample)
NZ (1) NZ198342A (enExample)
PH (1) PH18690A (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547519A (en) * 1982-05-24 1985-10-15 Warner-Lambert Company Tetrahydro-3,5-dioxo-1H-pyrrolizine-7a(5H)-carboxylic acid and benzyl esters and amides thereof and their use in reversing amnesia
US4559358A (en) * 1982-05-24 1985-12-17 Warner-Lambert Company 5-Oxo-2-pyrrolidinepropanoic acid and derivatives for reversing electroshock amnesia
US4525476A (en) * 1983-05-26 1985-06-25 Warner-Lambert Company N-[1-oxo-3-(5-oxo-2-pyrrolidinyl)propyl]-alpha-aminoacids and derivatives as cognition activators
US4551470A (en) * 1983-08-29 1985-11-05 Warner-Lambert Company Hexahydro-3,5-dioxo-1H-pyrrolizine-2-carboxylic acid and derivatives, and use for reversing electroconvulsive shock amnesia
US4530929A (en) * 1984-02-02 1985-07-23 Warner-Lambert Company Benzotricyclic nitrogen-containing diones and their use in reversing electroconvulsive shock-induced amnesia
US4562195A (en) * 1984-02-02 1985-12-31 Warner-Lambert Company Reversing amnesia with saturated tricyclic nitrogen-containing diones
US4548947A (en) * 1984-05-07 1985-10-22 Warner-Lambert Company 1-(Substituted-aryl)-dihydro-1H-pyrrolizine-3,5-[2H,6H-]diones and use for reversing amnesia
US4677098A (en) * 1985-11-22 1987-06-30 Warner-Lambert Company Substituted dihydro-1H-pyrolizine-3,5(2H,6H)-diones
US4663464A (en) * 1986-03-21 1987-05-05 Warner-Lambert Company Process for the preparation of dihydro-1H-pyrrolizine-3,5-(2H,6H)-dione
IT1233860B (it) * 1988-02-08 1992-04-21 Isf Spa Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa

Also Published As

Publication number Publication date
EP0048132A2 (en) 1982-03-24
GR75026B (enExample) 1984-07-12
EP0048132B1 (en) 1984-08-15
AU7479981A (en) 1982-03-25
ES505456A0 (es) 1982-08-16
NZ198342A (en) 1984-11-09
CA1154679A (en) 1983-10-04
FI812853L (fi) 1982-03-16
DD201797A5 (de) 1983-08-10
IE812133L (en) 1982-03-15
FI812853A7 (fi) 1982-03-16
HU184883B (en) 1984-10-29
ES8206526A1 (es) 1982-08-16
EP0048132A3 (en) 1982-05-12
NO813122L (no) 1982-03-16
AU545556B2 (en) 1985-07-18
IL63663A0 (en) 1981-11-30
PH18690A (en) 1985-09-05
US4372966A (en) 1983-02-08
DE3165563D1 (en) 1984-09-20
IL63663A (en) 1984-12-31

Similar Documents

Publication Publication Date Title
US4937267A (en) Method of treatment of obesity
EP0043659B1 (en) Clonidine derivatives useful in the treatment of diarrhoea
PL173725B1 (pl) Sól 5-[4-[2-(N-metylo-N-(2-pirydylo)amino)etoksy] benzylo]tiazolidyno-2,4-dionu z kwasem maleinowym oraz sposób wytwarzania soli 5-[4-[2-(N-metylo-N-(2-pirydylo)amino)etoksy] benzylo] tiazolidyno-2,4-dionu z kwasem maleinowym
IE51514B1 (en) Pharmaceutical compositions containing dihydro-1h-pyrrolizine-3,5(2h,6h)-dione as the active compound and their use as cognition activators
UA72495C2 (uk) N-[2-гідрокси-3-(1-піперидиніл)пропокси]піридин-1-оксид-3-карбоксіімідоїлхлорид, фармацевтична композиція та спосіб лікування інсулінорезистентності з його використанням
DE3811274A1 (de) Neue anwendungen von dopamin rezeptor-agonisten
JPS6028836B2 (ja) ５−メチル−イソフラボン誘導体の製造方法
IL30782A (en) Amino guanidines
US2835702A (en) Benzene 1, 3 disulfonamides possessing diuretic properties
US4039589A (en) α-Substituted benzhydrol derivatives and a process for the preparation thereof
JPS62181246A (ja) 生体活性ポリペプチド類に対し拮抗活性を有するグルタミン酸類およびアスパラギン酸類の新規酸素化アルキル誘導体およびその製造法
JPS58164583A (ja) フエノキシプロパノ−ルアミン誘導体
US3193458A (en) Method of lowering blood cholesterol level
US3541217A (en) Omicron-chlorobenzylaminoguanidine for treating bovine ketosis
JPH033671B2 (enExample)
US3979468A (en) 4'-Chloro-4-ethynylbiphenyl and method of preparing same
DE2034640B2 (enExample)
SU1217248A3 (ru) Способ получени производных 4-/2-окси-4-замещенных/ фенилнафталин-2-олов
US2899358A (en) Process
SU1014469A3 (ru) Способ получени 9-[3-(3,5-цис-диметилпиперазин)-пропил]-карбазола или его соли,или сольвата его соли
GB2197198A (en) Analgesic preparations
US2883392A (en) Process of and composition for combating epilepsy
US3294640A (en) Controlling blood sugar with sulfonyl pyrazoles
US3629418A (en) Process for producing an anti-depressant effect with piperazine quinolines
KR20040007476A (ko) 방광 과민증 치료제